
VP, Chief of Media Strategy @LifeSciComms. He/him. Formerly: @BioWorld, @ucbsoj alumn. 我学习汉语.
Richmond, CA
Joined July 2006
- Tweets4.8K
- Following3.1K
- Followers2.5K
- Likes2.5K
Michael Fitzhugh retweeted
Prasad out, per FDA spox (confirming WSJ reporting) cnbc.com/2026/03/06/fda-vacc…
Michael Fitzhugh retweeted
FDA Commissioner Makary says yesterday's CRL dump was just the beginning and that FDA plans to post them in "real time" going forward cnbc.com/video/2025/07/11/wa…
Michael Fitzhugh retweeted
It turns out, getting 50 million people healthcare coverage becomes more and more popular over time
Michael Fitzhugh retweeted
Bluebird Bio sells itself to Carlyle, SK Capital for less than $30 million statnews.com/2025/02/21/blue…
Michael Fitzhugh retweeted
It’s been exciting watching @bradloncar build out @BiotechTVHQ and I can’t wait to contribute. Reach out to me at [email protected] with your ideas and suggestions.
𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭: Today we are excited to welcome @RS_Flinn as BiotechTV's new 'AI in Biotech' contributor. Ryan is based in the Bay Area, and will be covering AI globally. Reach out if you have news.
Michael Fitzhugh retweeted
Major PPE mistake: California county leaves more than $10M worth of COVID protective gear out in the rain - ABC7 San Francisco abc7news.com/protective-gear…
Michael Fitzhugh retweeted
Mexico approves emergency use of Pfizer's COVID-19 pills reut.rs/3FuOUe0
Michael Fitzhugh retweeted
There may be some pain & correction in #biotech in 2022 - Media roundup at #BiotechShowcase - Clausen @cglifeagency Anderson @FierceBiotech Dunn @BusinessInsider Fitzhugh @BioWorld Jackson @thepinksheet Leuty @SFBIZronleuty @sfbizjournal
Michael Fitzhugh retweeted
Check out this science writing panel if considering a career! Held by my alma mater @SDSU which has one of the best programs in the nation. #saidit #journalism
Michael Fitzhugh retweeted
Mark your calendars for next Wednesday afternoon/evening — we'll try to make sense and break down the news that dominated #JPM22 and #BiotechShowcase
Excited to join the reporting pros of @rleuty_biotech, @ScripMandy, and @mfitz to discuss!
Our own @EClausen is moderating a "Media Round-Up" panel at #BiotechShowcase on 1/12 at 4:30 PT.
Panelists: @BusinessInsider's @AndrewE_Dunn, @PharmaScrip/@PharmaPinkSheet 's @ScripMandy, @BioWorld 's @mfitz & @SFBusinessTimes' @rleuty_biotech.
https://teapawt.net/t.co/6c5hM5YopY
Michael Fitzhugh retweeted
It's a fizzy drink that can be bolted onto a bar of soap and has no moving parts.
Michael Fitzhugh retweeted
Prenatal tests promise to detect rare genetic diseases in babies by scanning DNA.
Labs market them as "reliable." They tell women to have "total confidence" in results.
It turns out, the grave predictions made by those tests are usually wrong. (1/5)
nytimes.com/2022/01/01/upsho…
Michael Fitzhugh retweeted
Many investors voice strong opinions and make outsized investment bets. How about a radical alternative? @AdamMGrossman's suggestion: moderation. humbledollar.com/2022/01/a-m…
Michael Fitzhugh retweeted
Every year the @BioWorld team looks back and assesses the market-moving, life-changing stories and trends. From #COVID19 to #Alzheimers to #AI, take a look at what happened in 2021: bddy.me/31VYSrp
#2021biopharmatrends #bioworld
Michael Fitzhugh retweeted
Aduhelm incited many discussions in the biopharma industry. Michael Agadjanyan, president of Nuravax, and Robert Glanzman, #CMO of Clene Nanomedicine, debate the science of Aduhelm on the @BioWorld Insider Podcast with @LynnYoffee and Lee Landenberger:
https://teapawt.net/t.co/siiey49mwt
Michael Fitzhugh retweeted
Another excellent episode from @LynnYoffee and @mfitz of @BioWorld featuring @KyowaKirin_US Paul Testa. Listen here!
@russopartners @davidschull – at Manhattan, NY
Manufacturing processes have been one of the most affected sectors during #COVID19. #EVP of operations and supply chains for @KyowaKirin_US, Paul Testa, spoke to these issues with @LynnYoffee and @mfitz of @BioWorld Insider Podcast.
#TuneIn: https://teapawt.net/t.co/rmUjfZLiPd
Michael Fitzhugh retweeted
President of the Center for Medicine in the Public Interest, @PeterPitts, spoke with @LynnYoffee and @mfitz of @BioWorld Insider Podcast to discuss the #COVID19 impact on the @US_FDA and beyond.
Listen to the full podcast: bioworld.com/media/podcasts/…
Michael Fitzhugh retweeted
Monday commute? Check out this podcast from @BioWorld, where ED Joe Allen discusses march-in and @Merck's molnupiravir with @LynnYoffee and @mfitz.
Tune in now, via @clarivate! buff.ly/3aTf1yE
Michael Fitzhugh retweeted
“What we don’t know — about the lives of our neighbors and fellow citizens and why they think the way they do — is almost as important as what we do know,” writes @janecoaston. nyti.ms/2Z8k63R





























